03:23 AM EDT, 10/03/2025 (MT Newswires) -- Eric Swayze, Executive Vice President, Research, on October 01, 2025, sold 27,114 shares in Ionis Pharmaceuticals ( IONS ) for $1,793,744. Following the Form 4 filing with the SEC, Swayze has control over a total of 37,486 common shares of the company, with 37,302 shares held directly and 184 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/874015/000087401525000245/xslF345X05/edgardoc.xml